Sustainable development

Since their conception in the year 2000, we have been contributing to the United Nations Millennium Development Goals (MDGs) on many fronts. As these goals evolve into the Sustainable Development Goals (SDGs) we continue to play our part. By this we mean developing our business in a way that takes into account social, economic and environmental considerations; and striving to create a world that is fair, equitable and inclusive for future generations.

You will find below a snapshot of some of the health-related examples of our contributions to this agenda:

Eradicate extreme poverty and hunger

By supplying medicines and vaccines, we’re helping to fight diseases, such as polio and Lymphatic Filariasis that can leave people unable to support themselves and their family.

Achieve universal primary education

Treating children for diseases such as intestinal worms can improve their chances of attending school. We have pledged to donate up to 400 million treatments to enable the deworming of school-age children to the World Health Organization each year till 2020.

Promote gender equality and empower women

We have a range of community programmes that help women such as supporting the training of health workers. We also support development organisations to promote livelihood training for rural women.

Reduce child mortality

Over 80% of the 883 million doses of vaccines we delivered in 2012 went to developing countries. As part of that, we are increasing access to newer vaccines for pneumococcal disease and rotavirus through our partnership with the GAVI Alliance.

Improve maternal health

We reinvest 20% of any profits we make in Least Developed Countries back into those countries’ healthcare infrastructure.

For example, in Bangladesh, we are working with CARE International to train birth attendants and health providers and aim to reach over 410,000 women in three years.

Combat HIV/AIDs, malaria and other diseases

The biggest contribution we can make is through innovation. We have invested $300m so far to develop our malaria vaccine candidate in partnership with the PATH Malaria Vaccine Initiative and have a long history of researching medicines to fight HIV.

Ensure environmental stability

We have set ambitious goals to reduce carbon, water and waste from the sourcing of raw materials and the impacts of our own labs and factories, to the use and disposal of our products by patients and consumers.

Develop a global partnership for development

Partnerships are fundamental to the way we operate. In 2013, we formed an innovative partnership with Save the Children where we will work together to help save the lives of one million children.

Read more on our Save the Children Partnership